Articles

Boston Scientific, fully absorbable scaffold, FAST study, resorbable

Boston Scientific has initiated a study of the company's first fully resorbable drug-eluting scaffold system. The Fully Absorbable Scaffold Feasibility Study (FAST) is a prospective, single-arm...

cardiac rehab after angioplasty, rehabilitation, ACC, Randal J. Thomas, referral

Hospitals in the Midwest were more likely than others to refer patients for guideline-recommended cardiac rehabilitation following angioplasty, according to new original research. This is...

ACC, health policy statement, heart team, cardiovascular health

Building teams that include advanced practice providers can help cardiovascular practices meet the challenges of modern practice, according to a new health policy statement by the American College...

Thoratec, HeartMate PHP. CE Mark approval, SHIELD I

Thoratec announced that the HeartMate PHP (Percutaneous Heart Pump) received CE Mark approval, permitting sale in the European Union and other international countries. Approval was based on data...

carotid artery stenting, outcomes, JACC, Beau Hawkins, Robert Yeh, CARE Registry

Hospitals performing carotid artery stenting vary considerably in rates of in-hospital stroke or death, according to a study published in JACC: Cardiovascular Interventions. Those...

CardiAQ, Edwards, acquire, acquisition, Fortis, TMVI, mitral valve replacement

Edwards Lifesciences Corp. announced that it has agreed to acquire CardiAQ Valve Technologies Inc., a privately held company and developer of a transcatheter mitral valve replacement (TMVR) system...

platelet-like particles, PLPs, clotting, substitute, Carver, Lyon, NIBIB

Researchers have created tiny gel particles that can perform the same essential functions as platelets. The particles could one day be used to control excessive bleeding following traumatic injury...

Opsens Medical, FFR, OptoWire, OptoMonitor, FDA, fractional flow reserve

Opsens Inc. announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the OptoWire and OptoMonitor, its products developed to measure fractional flow reserve (FFR). This...

St. Jude Medical, OCT, ILUMIEN III, IVUS, angiography, PCI

St. Jude Medical, Inc. announced the launch of the ILUMIEN III clinical trial on June 30. ILUMIEN III is a prospective, international, randomized trial evaluating the clinical benefits of the...

C.R. Bard, LEVANT 2 results, Lutonix 035 DCB, drug coated balloon, PTA

C.R. Bard Inc. announced the publication of results from the LEVANT 2 study in the June 24, 2015, online issue of The New England Journal of Medicine. Results from LEVANT 2 demonstrated...